{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:22:14Z","timestamp":1722298934090},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,29]]},"DOI":"10.7759\/cureus.65645","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:53:15Z","timestamp":1722257595000},"source":"Crossref","is-referenced-by-count":0,"title":["Aspirin Compared to Other Thromboprophylactic Agents in Patients Following Total Hip Arthroplasty: A Literature Review"],"prefix":"10.7759","author":[{"given":"Joseph","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahel","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beshoy Effat","family":"Elkomos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guirgis","family":"Ebeidallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31777-X","article-title":"Hip replacement","volume":"392","author":"Ferguson RJ","year":"2018","unstructured":"Ferguson RJ, Palmer AJ, Taylor A, Porter ML, Malchau H, Glyn-Jones S. Hip replacement. Lancet. 2018, 392:1662-71. 10.1016\/S0140-6736(18)31777-X","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60457-7","article-title":"The operation of the century: total hip replacement","volume":"370","author":"Learmonth ID","year":"2007","unstructured":"Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007, 370:1508-19. 10.1016\/S0140-6736(07)60457-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-023-06860-6","article-title":"Total hip arthroplasty versus hemiarthroplasty in the treatment of active elderly patients over 75 years with displaced femoral neck fractures: a retrospective study","volume":"24","author":"Luo S","year":"2023","unstructured":"Luo S, Qin W, Yu L, Luo R, Liang W. Total hip arthroplasty versus hemiarthroplasty in the treatment of active elderly patients over 75 years with displaced femoral neck fractures: a retrospective study. BMC Musculoskelet Disord. 2023, 24:745. 10.1186\/s12891-023-06860-6","journal-title":"BMC Musculoskelet Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-21-07-S1","article-title":"The burden of hip osteoarthritis in the United States: epidemiologic and economic considerations","volume":"21 Suppl 1","author":"Nho SJ","year":"2013","unstructured":"Nho SJ, Kymes SM, Callaghan JJ, Felson DT. The burden of hip osteoarthritis in the United States: epidemiologic and economic considerations. J Am Acad Orthop Surg. 2013, 21 Suppl 1:S1-6. 10.5435\/JAAOS-21-07-S1","journal-title":"J Am Acad Orthop Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56090416","article-title":"An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020","volume":"56","author":"Santana DC","year":"2020","unstructured":"Santana DC, Emara AK, Orr MN, et al.. An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020. Medicina (Kaunas). 2020, 56:416. 10.3390\/medicina56090416","journal-title":"Medicina (Kaunas)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2019.03.004","article-title":"Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States","volume":"43","author":"Abe K","year":"2019","unstructured":"Abe K, Kuklina EV, Hooper WC, Callaghan WM. Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States. Semin Perinatol. 2019, 43:200-4. 10.1053\/j.semperi.2019.03.004","journal-title":"Semin Perinatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1906190","article-title":"Total hip arthroplasty or hemiarthroplasty for hip fracture","volume":"381","author":"Bhandari M","year":"2019","unstructured":"Bhandari M, Einhorn TA, Guyatt G, et al.. Total hip arthroplasty or hemiarthroplasty for hip fracture. N Engl J Med. 2019, 381:2199-208. 10.1056\/NEJMoa1906190","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.11.033","article-title":"The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs","volume":"137","author":"Grosse SD","year":"2016","unstructured":"Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016, 137:3-10. 10.1016\/j.thromres.2015.11.033","journal-title":"Thromb Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2016.10.020","article-title":"The incidence and economic burden of in-hospital venous thromboembolism in the United States","volume":"32","author":"Shahi A","year":"2017","unstructured":"Shahi A, Chen AF, Tan TL, Maltenfort MG, Kucukdurmaz F, Parvizi J. The incidence and economic burden of in-hospital venous thromboembolism in the United States. J Arthroplasty. 2017, 32:1063-6. 10.1016\/j.arth.2016.10.020","journal-title":"J Arthroplasty"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(86)80013-4","article-title":"Clinical features and diagnosis of venous thrombosis","volume":"8","author":"Hirsh J","year":"1986","unstructured":"Hirsh J, Hull RD, Raskob GE. Clinical features and diagnosis of venous thrombosis. J Am Coll Cardiol. 1986, 8:114B-27B. 10.1016\/s0735-1097(86)80013-4","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2002.6552","article-title":"Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis","volume":"108","author":"Myers D Jr","year":"2002","unstructured":"Myers D Jr, Farris D, Hawley A, et al.. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res. 2002, 108:212-21. 10.1006\/jsre.2002.6552","journal-title":"J Surg Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000001655","article-title":"Venous thromboembolism after major venous injuries: competing priorities","volume":"83","author":"Frank B","year":"2017","unstructured":"Frank B, Maher Z, Hazelton JP, et al.. Venous thromboembolism after major venous injuries: competing priorities. J Trauma Acute Care Surg. 2017, 83:1095-101. 10.1097\/TA.0000000000001655","journal-title":"J Trauma Acute Care Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.01050.x","article-title":"Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution","volume":"118","author":"Roth-Isigkeit A","year":"1999","unstructured":"Roth-Isigkeit A, Borstel TV, Seyfarth M, Schmucker P. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol. 1999, 118:242-6. 10.1046\/j.1365-2249.1999.01050.x","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1544230","article-title":"Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for intervention","volume":"41","author":"Dahl OE","year":"2015","unstructured":"Dahl OE, Harenberg J, Wexels F, Preissner KT. Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for intervention. Semin Thromb Hemost. 2015, 41:141-5. 10.1055\/s-0035-1544230","journal-title":"Semin Thromb Hemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(74)91069-1","article-title":"Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement","volume":"2","author":"Morris GK","year":"1974","unstructured":"Morris GK, Henry AP, Preston BJ. Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet. 1974, 2:797-800. 10.1016\/s0140-6736(74)91069-1","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Matharu GS","year":"2020","unstructured":"Matharu GS, Kunutsor SK, Judge A, Blom AW, Whitehouse MR. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2020, 180:376-84. 10.1001\/jamainternmed.2019.6108","journal-title":"JAMA Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2020.04.088","article-title":"Is aspirin as effective as the newer direct oral anticoagulants for venous thromboembolism prophylaxis after total hip and knee arthroplasty? An analysis from the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man","volume":"35","author":"Matharu GS","year":"2020","unstructured":"Matharu GS, Garriga C, Whitehouse MR, Rangan A, Judge A. Is aspirin as effective as the newer direct oral anticoagulants for venous thromboembolism prophylaxis after total hip and knee arthroplasty? An analysis from the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man. J Arthroplasty. 2020, 35:2631-9.e6. 10.1016\/j.arth.2020.04.088","journal-title":"J Arthroplasty"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-023-03816-3","article-title":"Aspirin prophylaxis is not associated with increased risk of venous thromboembolism in arthroplasty for femoral neck fractures: a non-inferiority study","volume":"34","author":"Habibi AA","year":"2024","unstructured":"Habibi AA, Brash A, Rozell JC, Ganta A, Schwarzkopf R, Arshi A. Aspirin prophylaxis is not associated with increased risk of venous thromboembolism in arthroplasty for femoral neck fractures: a non-inferiority study. Eur J Orthop Surg Traumatol. 2024, 34:1405-11. 10.1007\/s00590-023-03816-3","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-023-06750-x","article-title":"Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study","volume":"24","author":"Sidhu V","year":"2023","unstructured":"Sidhu V, Badge H, Churches T, Maree Naylor J, Adie S, A Harris I. Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study. BMC Musculoskelet Disord. 2023, 24:629. 10.1186\/s12891-023-06750-x","journal-title":"BMC Musculoskelet Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2023.11.030","article-title":"Trends in deep vein thrombosis prophylaxis after total hip arthroplasty: 2016 to 2021","volume":"48","author":"Moore MC","year":"2024","unstructured":"Moore MC, Dubin JA, Bains SS, Hameed D, Nace J, Delanois RE. Trends in deep vein thrombosis prophylaxis after total hip arthroplasty: 2016 to 2021. J Orthop. 2024, 48:77-83. 10.1016\/j.jor.2023.11.030","journal-title":"J Orthop"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2023.02.021","article-title":"Comparison of 90-day adverse events associated with aspirin and potent anticoagulation use for venous thromboembolism prophylaxis: a cohort study of 72,288 total knee and 35,142 total hip arthroplasty patients","volume":"38","author":"Singh G","year":"2023","unstructured":"Singh G, Prentice HA, Winston BA, Kroger EW. Comparison of 90-day adverse events associated with aspirin and potent anticoagulation use for venous thromboembolism prophylaxis: a cohort study of 72,288 total knee and 35,142 total hip arthroplasty patients. J Arthroplasty. 2023, 38:1602-12.e1. 10.1016\/j.arth.2023.02.021","journal-title":"J Arthroplasty"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.13416","article-title":"Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial","volume":"328","author":"Sidhu VS","year":"2022","unstructured":"Sidhu VS, Kelly TL, Pratt N, et al.. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. JAMA. 2022, 328:719-27. 10.1001\/jama.2022.13416","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.9408.ebo746","article-title":"American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"94","author":"Jacobs JJ","year":"2012","unstructured":"Jacobs JJ, Mont MA, Bozic KJ, et al.. American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am. 2012, 94:746-7. 10.2106\/JBJS.9408.ebo746","journal-title":"J Bone Joint Surg Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278460-aspirin-compared-to-other-thromboprophylactic-agents-in-patients-following-total-hip-arthroplasty-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:53:20Z","timestamp":1722257600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278460-aspirin-compared-to-other-thromboprophylactic-agents-in-patients-following-total-hip-arthroplasty-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.65645","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,29]]}}}